SIRNA TARGETING PRK2, WHICH IS HEPATITIS C VIRUS THERAPEUTIC AGENT

• 收藏
• 分享

专利权人:

University-Industry Foundation; Yonsei University

发明人:

OH, Jong-Won

申请号：

EP14872405

公开号：

EP3088523A4

申请日:

2014.12.19

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to an siRNA targeting PRK2, which is a hepatitis C virus therapeutic agent, and can be effectively used as a hepatitis C virus therapeutic agent since the systemic delivery into a living body, particularly hepatocytes, is possible through an siRNA targeting a host PRK2 gene, which shows an anti-HCV activity, or a lipid formulation thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/